Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Research from G.A. Dekaban and co-authors reveals new findings on cancer vaccines
May 26th, 2009
"Despite recent therapeutic advances, including the introduction of novel cytostatic drugs and therapeutic antibodies, many cancer patients will experience recurrent or metastatic disease. Current treatment options, particularly for those patients with metastatic breast, prostate, or skin cancers, are complex and have limited curative potential," researchers in Australia report. "Recent clinical trials, however. have shown that cell-based therapeutic vaccines may be used to generate broad-based. antitumor immune responses. Dendritic cells (DC) have proved to be the most efficacious cellular component for therapeutic vaccines, serving as both the adjuvant and antigen...
Source: Cancer Weekly (2009-05-26)
|
